A clinical pharmacokinetic study on the use of pegylated interferon in Egyptian children infected with hepatitis C /
Doaa Hamed Abdelaziz Yousef Ali
A clinical pharmacokinetic study on the use of pegylated interferon in Egyptian children infected with hepatitis C / دراسة حركية الدواء الإكلينيكية لعقار الإنترفيرون طويل المفعول فى الأطفال المصريين المصابين بالإلتهاب الكبدى الفيروسى سى Doaa Hamed Abdelaziz Yousef Ali ; Supervised Omaima N. Elgazayerly , Manal H. Elsayed , Nirmeen A. Sabry - Cairo : Doaa Hamed Abdelaziz Yousef Ali , 2012 - 144 P. : charts ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
The aim of this study is to clarify the pharmacokinetic profiles of pegylated interferon therapy (PEG-IFN - Ü- 2a (20 kDa)) in Egyptian HCV infected children and adolescents as well as determining the efficacy and safety of PEG - IFN / Ribavirin combination therapy . Thirty patients were recruited according to specific inclusion and exclusion criteria
Chronic hepatitis C Pegylated interferon Ribavirin
A clinical pharmacokinetic study on the use of pegylated interferon in Egyptian children infected with hepatitis C / دراسة حركية الدواء الإكلينيكية لعقار الإنترفيرون طويل المفعول فى الأطفال المصريين المصابين بالإلتهاب الكبدى الفيروسى سى Doaa Hamed Abdelaziz Yousef Ali ; Supervised Omaima N. Elgazayerly , Manal H. Elsayed , Nirmeen A. Sabry - Cairo : Doaa Hamed Abdelaziz Yousef Ali , 2012 - 144 P. : charts ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
The aim of this study is to clarify the pharmacokinetic profiles of pegylated interferon therapy (PEG-IFN - Ü- 2a (20 kDa)) in Egyptian HCV infected children and adolescents as well as determining the efficacy and safety of PEG - IFN / Ribavirin combination therapy . Thirty patients were recruited according to specific inclusion and exclusion criteria
Chronic hepatitis C Pegylated interferon Ribavirin